Algert Global’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Sell |
98,755
-22,125
| -18% | -$310K | 0.03% | 735 |
|
|
2025
Q1 | $1.89M | Buy |
120,880
+40,090
| +50% | +$627K | 0.05% | 617 |
|
|
2024
Q4 | $1.13M | Buy |
80,790
+8,310
| +11% | +$116K | 0.03% | 751 |
|
|
2024
Q3 | $674K | Buy |
72,480
+62,065
| +596% | +$577K | 0.02% | 838 |
|
|
2024
Q2 | $97K | Buy |
+10,415
| New | +$97K | ﹤0.01% | 1393 |
|
|
2022
Q4 | – | Sell |
-22,126
| Closed | -$423K | – | 1128 |
|
|
2022
Q3 | $423K | Buy |
+22,126
| New | +$423K | 0.03% | 856 |
|